Navigation Links
KICVentures Ramps Up AxioMed Freedom Cervical Disc Manufacturing to Meet OUS Orders and Expand Market Share Rapidly
Date:12/27/2018

AxioMed completed its initial production of the first 60 cervical discs for implantation at its new Boston facility, and is now raising growth capital to ramp up demand for orders already placed, and to have additional inventory to immediately expand market share against inferior ball and socket discs. The capital raise is targeted to qualified private investors with a $50,000 minimum per investor. This sum encourages more participation vs. institutions with deeper pockets because Dr. Chin, Managing Partner and CEO of KICVentures (AxioMed's parent company) believes this disc should have a grass roots success story.

About AxioMed LLC

AxioMed was founded to advance the standard of care for patients with degenerative spine conditions by progressing spine technology beyond fusion and first-generation artificial discs. Led by an experienced surgeon team and utilizing patented viscoelastic polymer technology, AxioMed has developed the next generation of artificial discs. AxioMed completed its U.S. IDE for the Lumbar Disc with over five years of clinical follow-up.

About KICVentures

KICVentures is a private investment company founded in 2005 by Harvard-trained Orthopedic Surgeon & Professor Dr. Kingsley R. Chin, who brings unique experience at the intersection of medicine, business and information technology. KICVentures is equipped with a strong advantage in identifying niche healthcare opportunities, and is headquartered in Boston, Mass.

Read the full story at https://www.prweb.com/releases/kicventures_ramps_up_axiomed_freedom_cervical_disc_manufacturing_to_meet_ous_orders_and_expand_market_share_rapidly/prweb15997208.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. DFG and Leopoldina: Recommendations on scientific freedom and scientific responsibility
2. Genetic circuit allows both individual freedom, collective good
3. Study shows Hera Therapeutics compound combats HPV types that cause most cervical cancer
4. Clearing cells to prevent cervical cancer
5. Current guidelines underestimate US cervical cancer incidence and older womens risk
6. Radiation therapy for cervical cancer increases risk for colorectal cancer
7. LSUHSC research reveals structure of master regulator and new drug target for autism, cervical cancer
8. International team completes systematic, genomic study of cervical cancer
9. Biocompare Releases Documentary on “What Researchers Need to Know about Antibody Manufacturing”
10. RoosterBio Inc. and Tissue Regeneration Therapeutics Inc. Announce Alliance Around Scale-up Manufacturing of Umbilical Cord Tissue Perivascular Cell Technology
11. ACEA Biosciences Joins Cell Manufacturing Research Initiative to Further Advance Cell Therapy Discovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2019)... ... May 20, 2019 , ... Pennsylvania College of Health ... 96.15% pass rate for first-time test takers of the National Council Licensure Examination ... 76.43% by nearly 20 points. , “This first-time pass rate is commendable ...
(Date:5/16/2019)... ... , ... In a FDA-contracted Standard Coordinating Body Workshop held at ... year, Asymmetrex founder and director James L. Sherley, M.D., Ph.D. predicted a ... stem cells. Many of the gathered participants dismissed this idea. Few argued ...
(Date:5/15/2019)... ... 2019 , ... The conventional method for characterizing brain tissues ... two-dimensional slices, placed on glass microscope slides and qualitatively evaluated after staining. The ... brain is a highly heterogenous and complex tissue that is challenging to evaluate ...
Breaking Biology News(10 mins):
(Date:5/2/2019)... , ... April 30, 2019 , ... The centuries old ... scale macro breweries to local craft breweries, and even home brewing clubs scattered across ... chemical and biological processes, that when mastered can produce a superb product. Students at ...
(Date:5/2/2019)... ... May 02, 2019 , ... Researchers ... present results documenting discrepancies between U.S. insurer policies for genetic testing and the ... for hereditary breast and ovarian cancer (HBOC). , Jill S. Dolinsky, ...
(Date:4/25/2019)... ... April 23, 2019 , ... Frank is an albino, deaf Great Dane. His owners ... him due to his health issues. Despite his hearing impairment, he was always an active ... two would play all day, every day. As the two grew, playtime became rougher and ...
(Date:4/18/2019)... ... April 18, 2019 , ... Taking ... that includes a chemical engineer at Worcester Polytechnic Institute (WPI) has developed a ... it possible to manufacture isobutanol and other biofuels more economically. , Isobutanol, like ...
Breaking Biology Technology: